Takeda, Lilly Actos Marketing Agreement Expires Ahead Of Schedule
This article was originally published in The Pink Sheet Daily
Executive Summary
Lilly will continue to market the diabetes treatment pioglitazone outside the U.S.
You may also be interested in...
Takeda Drops Phase II Diabetes Drug
Compound fails to measure up to exisiting treatments, firm says.
Future BIO Global Efforts Include International Relations, Greenwood Says
HAMBURG, Germany - Due to the increasingly global nature of biotechnology, the Biotechnology Industry Organization's board of directors will meet next month to discuss a proposal to expand its global reach and potentially create a department of international relations, BIO President Jim Greenwood said Nov. 13